Trial Profile
Phase II Clinical Study of JTE-052A - Dose finding study in patients with atopic dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Delgocitinib (Primary) ; Tacrolimus
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 28 Sep 2017 Primary endpoint (The percent change in modified Eczema Area Severity Index (m-EASI) score) has been met, according to the results published in the British Journal of Dermatology.
- 28 Sep 2017 Results published in the British Journal of Dermatology
- 15 Jun 2016 New trial record